Together, these results demonstrate that FTO-mediated SIK2 can promote autophagic flux and the enforced expression of SIK2 efficiently inhibits the progression and survival of ccRCC in vitro and in vivo. The gene discussed is SIK2; the disease is nonpapillary renal cell carcinoma.